Healthcare • Drug Manufacturers - Specialty & Generic
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if KMDA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Sentiment: neutral
Last trade: sell 27 days ago
Red flags: 26
51 filers reported a long position in KMDA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Phoenix Financial Ltd. | $12.1M | 1.7M | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $5.4M | 742.4K | -2.7% |
| WELLS FARGO & COMPANY/MN | $4.3M | 592.1K | -0.9% |
| DIMENSIONAL FUND ADVISORS LP | $2.2M | 301.7K | New |
| ARK Investment Management LLC | $1.9M | 263.3K | -2.3% |
| Huntleigh Advisors, Inc. | $1.2M | 162.6K | +4.6% |
| ACADIAN ASSET MANAGEMENT LLC | $1.1M | 154.4K | -58.5% |
| TWO SIGMA INVESTMENTS, LP | $1.1M | 151.1K | -22.2% |
| RENAISSANCE GROUP LLC | $916.7K | 124.9K | -0.8% |
| MARSHALL WACE, LLP | $551.8K | 75.2K | -49.9% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.